FDA Clears NSAID/Triptan Combo for Migraine in Adults
The US Food and Drug Administration (FDA) has approved a novel formulation combining rizatriptan and the nonsteroidal anti-inflammatory drug meloxicam
All posts by Raleigh Schroeder
Read More »
Raleigh Schroeder
21:22
India’s Big Signal On Tariff: Duty On Harley Cut Amid Donald Trump’s Demand
India's Big Signal On Tariff: Duty On Harley Cut Amid Donald Trump's Demand NDTV...
Raleigh Schroeder
06:22
North America Nimesulide Dispersible Tablet Market: Forthcoming Trends and Share Analysis by 2032
North America Nimesulide Dispersible Tablet Market Overview and Insights: According to IMR Market Reports, North America Nimesulide Dispersible Tablet Market is expected to
Raleigh Schroeder
16:24
How to Read All the Cosmere Books in Order
Brandon Sanderson wrote the largest interconnected fantasy universe in literary history. But where to begin...
Raleigh Schroeder
08:29
Anti-Israel organization files complaint in Sweden against visiting IDF soldier for ‘war crimes, crimes against humanity and genocide’
Anti-Israel organization files complaint in Sweden against visiting IDF soldier for 'war crimes, crimes against humanity and genocide...
Raleigh Schroeder
12:22
Budget 2025 LIVE Updates | FM Nirmala Sitharaman concludes stakeholder consultations
Budget 2025 LIVE Updates | Stock markets will also remain open on the Saturday, February 1 on account of the
Raleigh Schroeder
11:19
USD/CAD depreciates to near 1.4400 as improved Oil prices support the Canadian Dollar
USD/CAD remains tepid following two days of gains, trading around 1.4410 during the Asian hours on Friday...
Raleigh Schroeder
09:21
Congress to vote on new restrictions on US investment in China
Congress is set to vote in the coming days on legislation restricting US investments in China as part of a
Raleigh Schroeder
08:22
Hotel Indigo opens its doors
IHG Hotels & Resorts continues to expand its presence in Texas with the opening of Hotel Indigo Irving - Las
Raleigh Schroeder
15:26
Update on Regulatory Review of Lecanemab for Early Alzheimer’s Disease in Australia
TOKYO and CAMBRIDGE, Mass., Oct 17, 2024 - (JCN Newswire) - Eisai Co., Ltd. and Biogen Inc. announced today that
